Inventor · disambiguated record
Daohong Zhou
Also filed as: ZHOU DAOHONG
10 granted patents·11 pending applications·10 citations·filing 2003–2022
81Inventor score
Top patents by PatentIndex Score
21 records- 0189US10071087B2Compositions and methods for selectively depleting senescent cellsBIOVENTURES LLC·Filed 2015·Granted Sep 11, 2018·6 cites·10 claims
- 0281US10807977B2Compounds that induce degradation of anti-apoptotic Bcl-2 family proteins and the uses thereofBIOVENTURES LLC·Filed 2017·Granted Oct 20, 2020·2 cites·19 claims
- 0378US10758524B2Compositions and methods for selectively depleting senescent cellsBIOVENTURES LLC·Filed 2018·Granted Sep 1, 2020·1 cites·11 claims
- 0470US11331328B2Compositions and methods for inhibiting antiapoptotic Bcl-2 proteins as anti-aging agentsUNIV ARKANSAS·Filed 2015·Granted May 17, 2022·1 cites·3 claims
- 0565US10137154B2Methods and compositions for expanding long-term hematopoietic stem cell populationsUNIV ARKANSAS·Filed 2014·Granted Nov 27, 2018·0 cites·3 claims
- 0660US12219938B2Mouse model of alcohol-induced liver cancerUNIV FLORIDA·Filed 2021·Granted Feb 11, 2025·0 cites·14 claims
- 0758US11319316B2Compounds that induce degradation of anti-apoptotic Bcl-2 family proteins and the uses thereofBIOVENTURES LLC·Filed 2020·Granted May 3, 2022·0 cites·21 claims
- 0857US2019046578A1Methods and compositions for expanding long-term hematopoietic stem cell populationsBIOVENTURES LLC·Filed 2018·Application pending·0 cites
- 0955US2023330237A1Modulators of nuclear receptor subfamily 4 group a member 1 (nr4a1) and uses thereofUNIV FLORIDA·Filed 2021·Application pending·0 cites
- 1050US2024398764A1Methods of treating diseases associated with senescent cell accumulationUNIV FLORIDA·Filed 2022·Application pending·0 cites
- 1150US2025057963A1Discovery of piperlongumine as a novel e3 ligase ligandUNIV FLORIDA·Filed 2022·Application pending·0 cites
- 1249US2007184021A1Use of caspase inhibitors as a therapeutic agent against radiation-induced injuryZHOU DAOHONG·Filed 2003·Application pending·0 cites
- 1348US12118414B2BCL-2 proteins degraders for cancer treatmentBIOVENTURES LLC·Filed 2019·Granted Oct 15, 2024·0 cites·20 claims
- 1448US2025154141A1Bcl-xl/bcl-2 dual degraders for treatment of cancersUNIV FLORIDA·Filed 2022·Application pending·0 cites
- 1546US2019054097A1Compositions targeting senescent cells and the uses thereofBIOVENTURES LLC·Filed 2018·Application pending·0 cites
- 1643US12441722B2Therapeutic agents and methods of treatmentUNIV FLORIDA·Filed 2021·Granted Oct 14, 2025·0 cites·22 claims
- 1743US12084423B2Piperlongumine analogues and uses thereofBIOVENTURES LLC·Filed 2018·Granted Sep 10, 2024·0 cites·17 claims
- 1843US2018002431A1FAS AND DRs ARE NOVEL MOLECULAR TARGETS OF SENESCENT CELLSBIOVENTURES LLC·Filed 2016·Application pending·0 cites
- 1939US2022169628A1Therapeutic agents and methods of treatmentUNIV FLORIDA·Filed 2020·Application pending·0 cites
- 2037US2018021323A1Flip - a selective molecular target of senescent cellsBIOVENTURES LLC·Filed 2016·Application pending·0 cites
- 2126US2007244076A1Site and Rate Selective Prodrug Formulations of D609 with Antioxidant and Anticancer ActivityMUSC FOUNDATION RES DEV·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Daohong Zhou files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →